Report Detail

Medical Devices & Consumables Global Non-Invasive Blood Glucose Monitoring Devices Market Insights and Forecast to 2026

  • RnM4171979
  • |
  • 28 August, 2020
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Non-Invasive Blood Glucose Monitoring Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Blood Glucose Monitoring Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Non-Invasive Blood Glucose Monitoring Devices market is segmented into
MIR/NIR (Mid/Near Infrared Spectroscopy)
Raman Spectroscopy
Occlusion Spectroscopy
Optical Coherence Tomography
Photoacoustic Spectroscopy
Electromagnetic
Fluorescence
Other

Segment by Application, the Non-Invasive Blood Glucose Monitoring Devices market is segmented into
Hospitals
Clinics
Home Care Settings
Other

Regional and Country-level Analysis
The Non-Invasive Blood Glucose Monitoring Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Non-Invasive Blood Glucose Monitoring Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Non-Invasive Blood Glucose Monitoring Devices Market Share Analysis

Non-Invasive Blood Glucose Monitoring Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Non-Invasive Blood Glucose Monitoring Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Non-Invasive Blood Glucose Monitoring Devices business, the date to enter into the Non-Invasive Blood Glucose Monitoring Devices market, Non-Invasive Blood Glucose Monitoring Devices product introduction, recent developments, etc.
The major vendors covered:
Abbott
BD Medical
Medtronic
Sanofi
Roche Diagnostics
Animas Technologies
Bayer Healthcare
Cercacor
Pendragon Medical
OrSense
Nova Biomedical
Dexcom
Terumo
Tosoh Bioscience


1 Study Coverage

  • 1.1 Non-Invasive Blood Glucose Monitoring Devices Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Non-Invasive Blood Glucose Monitoring Devices Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Growth Rate by Type
    • 1.4.2 MIR/NIR (Mid/Near Infrared Spectroscopy)
    • 1.4.3 Raman Spectroscopy
    • 1.4.4 Occlusion Spectroscopy
    • 1.4.5 Optical Coherence Tomography
    • 1.4.6 Photoacoustic Spectroscopy
    • 1.4.7 Electromagnetic
    • 1.4.8 Fluorescence
    • 1.4.9 Other
  • 1.5 Market by Application
    • 1.5.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Home Care Settings
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size, Estimates and Forecasts
    • 2.1.1 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Non-Invasive Blood Glucose Monitoring Devices Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Non-Invasive Blood Glucose Monitoring Devices Production Estimates and Forecasts 2015-2026
  • 2.2 Global Non-Invasive Blood Glucose Monitoring Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Manufacturers Geographical Distribution
  • 2.4 Key Trends for Non-Invasive Blood Glucose Monitoring Devices Markets & Products
  • 2.5 Primary Interviews with Key Non-Invasive Blood Glucose Monitoring Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Non-Invasive Blood Glucose Monitoring Devices Manufacturers by Production Capacity
    • 3.1.1 Global Top Non-Invasive Blood Glucose Monitoring Devices Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Non-Invasive Blood Glucose Monitoring Devices Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Non-Invasive Blood Glucose Monitoring Devices Manufacturers Market Share by Production
  • 3.2 Global Top Non-Invasive Blood Glucose Monitoring Devices Manufacturers by Revenue
    • 3.2.1 Global Top Non-Invasive Blood Glucose Monitoring Devices Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Non-Invasive Blood Glucose Monitoring Devices Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Non-Invasive Blood Glucose Monitoring Devices Revenue in 2019
  • 3.3 Global Non-Invasive Blood Glucose Monitoring Devices Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Non-Invasive Blood Glucose Monitoring Devices Production by Regions

  • 4.1 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Non-Invasive Blood Glucose Monitoring Devices Regions by Production (2015-2020)
    • 4.1.2 Global Top Non-Invasive Blood Glucose Monitoring Devices Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Non-Invasive Blood Glucose Monitoring Devices Production (2015-2020)
    • 4.2.2 North America Non-Invasive Blood Glucose Monitoring Devices Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Non-Invasive Blood Glucose Monitoring Devices Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Non-Invasive Blood Glucose Monitoring Devices Production (2015-2020)
    • 4.3.2 Europe Non-Invasive Blood Glucose Monitoring Devices Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Non-Invasive Blood Glucose Monitoring Devices Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Non-Invasive Blood Glucose Monitoring Devices Production (2015-2020)
    • 4.4.2 China Non-Invasive Blood Glucose Monitoring Devices Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Non-Invasive Blood Glucose Monitoring Devices Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Non-Invasive Blood Glucose Monitoring Devices Production (2015-2020)
    • 4.5.2 Japan Non-Invasive Blood Glucose Monitoring Devices Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Non-Invasive Blood Glucose Monitoring Devices Import & Export (2015-2020)

5 Non-Invasive Blood Glucose Monitoring Devices Consumption by Region

  • 5.1 Global Top Non-Invasive Blood Glucose Monitoring Devices Regions by Consumption
    • 5.1.1 Global Top Non-Invasive Blood Glucose Monitoring Devices Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Non-Invasive Blood Glucose Monitoring Devices Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Non-Invasive Blood Glucose Monitoring Devices Consumption by Application
    • 5.2.2 North America Non-Invasive Blood Glucose Monitoring Devices Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Non-Invasive Blood Glucose Monitoring Devices Consumption by Application
    • 5.3.2 Europe Non-Invasive Blood Glucose Monitoring Devices Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Consumption by Application
    • 5.4.2 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Non-Invasive Blood Glucose Monitoring Devices Consumption by Application
    • 5.5.2 Central & South America Non-Invasive Blood Glucose Monitoring Devices Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Consumption by Application
    • 5.6.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size by Type (2015-2020)
    • 6.1.1 Global Non-Invasive Blood Glucose Monitoring Devices Production by Type (2015-2020)
    • 6.1.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Type (2015-2020)
    • 6.1.3 Non-Invasive Blood Glucose Monitoring Devices Price by Type (2015-2020)
  • 6.2 Global Non-Invasive Blood Glucose Monitoring Devices Market Forecast by Type (2021-2026)
    • 6.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Production Forecast by Type (2021-2026)
    • 6.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Price Forecast by Type (2021-2026)
  • 6.3 Global Non-Invasive Blood Glucose Monitoring Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Abbott
    • 8.1.1 Abbott Corporation Information
    • 8.1.2 Abbott Overview
    • 8.1.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Abbott Product Description
    • 8.1.5 Abbott Related Developments
  • 8.2 BD Medical
    • 8.2.1 BD Medical Corporation Information
    • 8.2.2 BD Medical Overview
    • 8.2.3 BD Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 BD Medical Product Description
    • 8.2.5 BD Medical Related Developments
  • 8.3 Medtronic
    • 8.3.1 Medtronic Corporation Information
    • 8.3.2 Medtronic Overview
    • 8.3.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Medtronic Product Description
    • 8.3.5 Medtronic Related Developments
  • 8.4 Sanofi
    • 8.4.1 Sanofi Corporation Information
    • 8.4.2 Sanofi Overview
    • 8.4.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Sanofi Product Description
    • 8.4.5 Sanofi Related Developments
  • 8.5 Roche Diagnostics
    • 8.5.1 Roche Diagnostics Corporation Information
    • 8.5.2 Roche Diagnostics Overview
    • 8.5.3 Roche Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Roche Diagnostics Product Description
    • 8.5.5 Roche Diagnostics Related Developments
  • 8.6 Animas Technologies
    • 8.6.1 Animas Technologies Corporation Information
    • 8.6.2 Animas Technologies Overview
    • 8.6.3 Animas Technologies Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Animas Technologies Product Description
    • 8.6.5 Animas Technologies Related Developments
  • 8.7 Bayer Healthcare
    • 8.7.1 Bayer Healthcare Corporation Information
    • 8.7.2 Bayer Healthcare Overview
    • 8.7.3 Bayer Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Bayer Healthcare Product Description
    • 8.7.5 Bayer Healthcare Related Developments
  • 8.8 Cercacor
    • 8.8.1 Cercacor Corporation Information
    • 8.8.2 Cercacor Overview
    • 8.8.3 Cercacor Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Cercacor Product Description
    • 8.8.5 Cercacor Related Developments
  • 8.9 Pendragon Medical
    • 8.9.1 Pendragon Medical Corporation Information
    • 8.9.2 Pendragon Medical Overview
    • 8.9.3 Pendragon Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Pendragon Medical Product Description
    • 8.9.5 Pendragon Medical Related Developments
  • 8.10 OrSense
    • 8.10.1 OrSense Corporation Information
    • 8.10.2 OrSense Overview
    • 8.10.3 OrSense Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 OrSense Product Description
    • 8.10.5 OrSense Related Developments
  • 8.11 Nova Biomedical
    • 8.11.1 Nova Biomedical Corporation Information
    • 8.11.2 Nova Biomedical Overview
    • 8.11.3 Nova Biomedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Nova Biomedical Product Description
    • 8.11.5 Nova Biomedical Related Developments
  • 8.12 Dexcom
    • 8.12.1 Dexcom Corporation Information
    • 8.12.2 Dexcom Overview
    • 8.12.3 Dexcom Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Dexcom Product Description
    • 8.12.5 Dexcom Related Developments
  • 8.13 Terumo
    • 8.13.1 Terumo Corporation Information
    • 8.13.2 Terumo Overview
    • 8.13.3 Terumo Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 Terumo Product Description
    • 8.13.5 Terumo Related Developments
  • 8.14 Tosoh Bioscience
    • 8.14.1 Tosoh Bioscience Corporation Information
    • 8.14.2 Tosoh Bioscience Overview
    • 8.14.3 Tosoh Bioscience Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.14.4 Tosoh Bioscience Product Description
    • 8.14.5 Tosoh Bioscience Related Developments

9 Non-Invasive Blood Glucose Monitoring Devices Production Forecast by Regions

  • 9.1 Global Top Non-Invasive Blood Glucose Monitoring Devices Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Non-Invasive Blood Glucose Monitoring Devices Regions Forecast by Production (2021-2026)
  • 9.3 Key Non-Invasive Blood Glucose Monitoring Devices Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Non-Invasive Blood Glucose Monitoring Devices Consumption Forecast by Region

  • 10.1 Global Non-Invasive Blood Glucose Monitoring Devices Consumption Forecast by Region (2021-2026)
  • 10.2 North America Non-Invasive Blood Glucose Monitoring Devices Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Non-Invasive Blood Glucose Monitoring Devices Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Non-Invasive Blood Glucose Monitoring Devices Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Non-Invasive Blood Glucose Monitoring Devices Sales Channels
    • 11.2.2 Non-Invasive Blood Glucose Monitoring Devices Distributors
  • 11.3 Non-Invasive Blood Glucose Monitoring Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Non-Invasive Blood Glucose Monitoring Devices Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Non-Invasive Blood Glucose Monitoring Devices Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Non-Invasive Blood Glucose Monitoring Devices Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on Non-Invasive Blood Glucose Monitoring Devices. Industry analysis & Market Report on Non-Invasive Blood Glucose Monitoring Devices is a syndicated market report, published as Global Non-Invasive Blood Glucose Monitoring Devices Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Non-Invasive Blood Glucose Monitoring Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,934.70
    5,902.05
    7,869.40
    4,581.50
    6,872.25
    9,163.00
    760,137.00
    1,140,205.50
    1,520,274.00
    408,415.00
    612,622.50
    816,830.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report